Iowa Court Offers Limited Boost To Generic-Drug Injury Suits

By Sindhu Sundar (July 15, 2014, 8:45 PM EDT) -- The Iowa Supreme Court's recent decision to allow a consumer to sue a generic-drug maker over its alleged failure to update a warning label offers a toehold for plaintiffs struggling to overcome the landmark Mensing decision, but attorneys say it may still require them to show that their doctors were not aware of the latest warnings about the medication.

The state's highest court on Friday joined the majority of courts with its ruling in Huck v. Wyeth that brand-name makers of metoclopramide, a heartburn medication they sold as Reglan, could not be held liable for injuries allegedly caused by generics....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!